TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0720
-0.0130 (-15.29%)
At close: Jan 30, 2026
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €6.77 million as of January 30, 2026. Its market cap has decreased by -2.34% in one year.
Market Cap
6.77M
Enterprise Value
6.43M
Revenue
27.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.07
Market Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 6.77M, a decrease of -84.29%. That is a compound annual growth rate of -17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.77M | 10.43% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advicenne | 23.72M |
| genOway Société anonyme | 22.77M |
| Poxel | 21.49M |
| Aelis Farma | 21.00M |
| GenSight Biologics | 17.40M |
| NFL Biosciences | 16.25M |
| Oncodesign Precision Medicine Société anonyme | 10.18M |
| Plant Advanced Technologies | 8.75M |